Pandemic Prevention: how Europe can lead the fight against AMR

Memo

The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. New business models, investment into antimicrobials R and D, and reducing dependence on antibiotics are all part of the strategy required to tackle AMR, in 2022 and beyond.Join us for this timely virtual event Pandemic Prevention: how Europe can lead the fight against AMR, on 16 November at 14:00-15:30 CET, to discuss how we can drive investment in antimicrobials R and D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.This online event, an EFPIA initiative, in collaboration with Reuters Events, brings together experts from Carb-X, CRA, EFPIA, and more for a conversation on how public institutions and stakeholders can work together to find sustainable solutions to support antimicrobial pipelines.View the full programme and register for FREE here. Speakers: Prof. Kevin Outterson, Professor and Executive Director, CARB-X, Tim Wilsdon, Vice President, Life Sciences, CRA, Kristine Peers, General Counsel, EFPIATime: 14:00 - 15:30